Table II.
Gene ontology and pathway enrichment analysis for DEGs.
| Category | GO term | Description | Count | P-value |
|---|---|---|---|---|
| BP | 0000278 | Mitotic cell cycle | 10 | 7.97×10−7 |
| BP | 0022403 | Cell cycle phase | 10 | 2.02×10−6 |
| BP | 0022402 | Cell cycle process | 11 | 3.17×10−6 |
| BP | 0007049 | Cell cycle | 12 | 7.86×10−6 |
| BP | 0048015 | Phosphoinositide-mediated signaling | 5 | 1.16×10−4 |
| CC | 0015630 | Microtubular cytoskeleton | 8 | 7.31×1044 |
| CC | 0005819 | Spindle | 5 | 7.43×10−5 |
| CC | 0044430 | Cytoskeletal part | 10 | 1.02×10−3 |
| CC | 0005694 | Chromosome | 7 | 1.64×10−3 |
| CC | 0043228 | Non-membrane-bound organelle | 16 | 2.83×10−3 |
| MF | 0008009 | Chemokine activity | 3 | 7.17×10−3 |
| MF | 0042379 | Chemokine receptor binding | 3 | 8.10×10−3 |
| KEGG | hsa04115 | p53 signaling pathway | 3 | 1.87×10−2 |
If there were >5 terms enriched by DEGs in this category, the top 5 terms were selected according to the P-value. Count refers to the number of genes significantly enriched in this term. DEGs, differentially-expressed genes; GO, gene ontology; BP, biological process; CC, cellular component; MF, molecular function; KEGG, Kyoto Encyclopedia of Genes and Genomes.